Sypsa Vana, Roussos Sotirios, Engeli Vasiliki, Paraskevis Dimitrios, Tsiodras Sotirios, Hatzakis Angelos
Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Vaccines (Basel). 2022 Mar 18;10(3):470. doi: 10.3390/vaccines10030470.
Vaccine hesitancy is a major barrier to achieving large-scale COVID-19 vaccination. We report trends in vaccination intention and associated determinants from surveys in the adult general population in Greece. Four cross-sectional phone surveys were conducted in November 2020 and February, April and May 2021 on nationally representative samples of adults in Greece. Multinomial logistic regression was used on the combined data of the surveys to evaluate independent predictors of vaccination unwillingness/uncertainty. Vaccination intention increased from 67.6% in November 2020 to 84.8% in May 2021. Individuals aged 65 years or older were more willing to be vaccinated (May 2021: 92.9% vs. 79.5% in 18−39 years, p < 0.001) but between age-groups differences decreased over time. Vaccination intention increased substantially in both men and women, though earlier among men, and was higher in individuals with prograduate education (May 2021: 91.3% vs. 84.0% up to junior high). From multivariable analysis, unwillingness and/or uncertainty to be vaccinated was associated with younger age, female gender (in particular in the April 2021 survey), lower educational level and living with a child ≤12 years old. Among those with vaccine hesitancy, concerns about vaccine effectiveness declined over time (21.6% in November 2020 vs. 9.6% in May 2021, p = 0.014) and were reported more often by men; safety concerns remained stable over time (66.3% in November 2020 vs. 62.1% in May 2021, p = 0.658) and were reported more often by women. In conclusion, vaccination intention increased substantially over time. Tailored communication is needed to address vaccine hesitancy and concerns regarding vaccine safety.
疫苗犹豫是实现大规模新冠疫苗接种的主要障碍。我们报告了希腊成年普通人群调查中疫苗接种意愿及相关决定因素的趋势。2020年11月以及2021年2月、4月和5月对希腊具有全国代表性的成年样本进行了四次横断面电话调查。对调查的合并数据使用多项逻辑回归来评估疫苗接种不愿意/不确定的独立预测因素。疫苗接种意愿从2020年11月的67.6%升至2021年5月的84.8%。65岁及以上的人更愿意接种疫苗(2021年5月:92.9%,而18 - 39岁人群为79.5%,p < 0.001),但不同年龄组之间的差异随时间减小。男性和女性的疫苗接种意愿均大幅上升,不过男性上升得更早,且接受研究生教育的人疫苗接种意愿更高(2021年5月:91.3%,而初中及以下学历人群为84.0%)。多变量分析显示,疫苗接种的不愿意和/或不确定与年龄较小、女性(特别是在2021年4月的调查中)、教育水平较低以及与12岁及以下儿童同住有关。在那些有疫苗犹豫的人群中,对疫苗有效性的担忧随时间下降(2020年11月为21.6%,2021年5月为9.6%,p = 0.014),且男性报告的频率更高;对安全性的担忧随时间保持稳定(2020年11月为66.3%,2021年5月为62.1%,p = 0.658),且女性报告的频率更高。总之,疫苗接种意愿随时间大幅上升。需要进行有针对性的沟通,以解决疫苗犹豫问题以及对疫苗安全性的担忧。